Last reviewed · How we verify

Metronidazole vaginal suppositories

Peking University Shenzhen Hospital · FDA-approved active Small molecule Quality 2/100

Metronidazole vaginal suppositories is a Small molecule drug developed by Peking University Shenzhen Hospital. It is currently FDA-approved.

At a glance

Generic nameMetronidazole vaginal suppositories
SponsorPeking University Shenzhen Hospital
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Metronidazole vaginal suppositories

What is Metronidazole vaginal suppositories?

Metronidazole vaginal suppositories is a Small molecule drug developed by Peking University Shenzhen Hospital.

Who makes Metronidazole vaginal suppositories?

Metronidazole vaginal suppositories is developed and marketed by Peking University Shenzhen Hospital (see full Peking University Shenzhen Hospital pipeline at /company/peking-university-shenzhen-hospital).

What development phase is Metronidazole vaginal suppositories in?

Metronidazole vaginal suppositories is FDA-approved (marketed).

Related